Polyclonal secondary FGFR2 mutations drive acquired resistance to FGFR inhibition in FGFR2 fusion-positive cholangiocarcinoma patients. Goyal, L., Saha, S. K, Liu, L. Y, Siravegna, G., Leshchiner, I., Ahronian, L. G, Lennerz, J. K, Vu, P., Mussolin, B., Reyes, S., & others Cancer Research, 77(13_Supplement):4114–4114, The American Association for Cancer Research, 2017. bibtex @article{goyal2017polyclonal,
title={Polyclonal secondary FGFR2 mutations drive acquired resistance to FGFR inhibition in FGFR2 fusion-positive cholangiocarcinoma patients},
author={Goyal, Lipika and Saha, Supriya K and Liu, Leah Y and Siravegna, Giulia and Leshchiner, Ignaty and Ahronian, Leanne G and Lennerz, Jochen K and Vu, Phuong and Mussolin, Benedetta and Reyes, Stephanie and others},
journal={Cancer Research},
volume={77},
number={13\_Supplement},
pages={4114--4114},
year={2017},
publisher={The American Association for Cancer Research}
}
Downloads: 0
{"_id":"7qm97kwNMqaoaX7zz","bibbaseid":"goyal-saha-liu-siravegna-leshchiner-ahronian-lennerz-vu-etal-polyclonalsecondaryfgfr2mutationsdriveacquiredresistancetofgfrinhibitioninfgfr2fusionpositivecholangiocarcinomapatients-2017","author_short":["Goyal, L.","Saha, S. K","Liu, L. Y","Siravegna, G.","Leshchiner, I.","Ahronian, L. G","Lennerz, J. K","Vu, P.","Mussolin, B.","Reyes, S.","others"],"bibdata":{"bibtype":"article","type":"article","title":"Polyclonal secondary FGFR2 mutations drive acquired resistance to FGFR inhibition in FGFR2 fusion-positive cholangiocarcinoma patients","author":[{"propositions":[],"lastnames":["Goyal"],"firstnames":["Lipika"],"suffixes":[]},{"propositions":[],"lastnames":["Saha"],"firstnames":["Supriya","K"],"suffixes":[]},{"propositions":[],"lastnames":["Liu"],"firstnames":["Leah","Y"],"suffixes":[]},{"propositions":[],"lastnames":["Siravegna"],"firstnames":["Giulia"],"suffixes":[]},{"propositions":[],"lastnames":["Leshchiner"],"firstnames":["Ignaty"],"suffixes":[]},{"propositions":[],"lastnames":["Ahronian"],"firstnames":["Leanne","G"],"suffixes":[]},{"propositions":[],"lastnames":["Lennerz"],"firstnames":["Jochen","K"],"suffixes":[]},{"propositions":[],"lastnames":["Vu"],"firstnames":["Phuong"],"suffixes":[]},{"propositions":[],"lastnames":["Mussolin"],"firstnames":["Benedetta"],"suffixes":[]},{"propositions":[],"lastnames":["Reyes"],"firstnames":["Stephanie"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["others"],"suffixes":[]}],"journal":"Cancer Research","volume":"77","number":"13_Supplement","pages":"4114–4114","year":"2017","publisher":"The American Association for Cancer Research","bibtex":"@article{goyal2017polyclonal,\n title={Polyclonal secondary FGFR2 mutations drive acquired resistance to FGFR inhibition in FGFR2 fusion-positive cholangiocarcinoma patients},\n author={Goyal, Lipika and Saha, Supriya K and Liu, Leah Y and Siravegna, Giulia and Leshchiner, Ignaty and Ahronian, Leanne G and Lennerz, Jochen K and Vu, Phuong and Mussolin, Benedetta and Reyes, Stephanie and others},\n journal={Cancer Research},\n volume={77},\n number={13\\_Supplement},\n pages={4114--4114},\n year={2017},\n publisher={The American Association for Cancer Research}\n}\n\n","author_short":["Goyal, L.","Saha, S. K","Liu, L. Y","Siravegna, G.","Leshchiner, I.","Ahronian, L. G","Lennerz, J. K","Vu, P.","Mussolin, B.","Reyes, S.","others"],"key":"goyal2017polyclonal-1","id":"goyal2017polyclonal-1","bibbaseid":"goyal-saha-liu-siravegna-leshchiner-ahronian-lennerz-vu-etal-polyclonalsecondaryfgfr2mutationsdriveacquiredresistancetofgfrinhibitioninfgfr2fusionpositivecholangiocarcinomapatients-2017","role":"author","urls":{},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/network/files/aX4e85mNvLnP28bmF","dataSources":["9CnzWbeQFsvTLJme6","N3rXpkDkdbEvNCA76","hky9vNrwc9uGBMQ9h"],"keywords":[],"search_terms":["polyclonal","secondary","fgfr2","mutations","drive","acquired","resistance","fgfr","inhibition","fgfr2","fusion","positive","cholangiocarcinoma","patients","goyal","saha","liu","siravegna","leshchiner","ahronian","lennerz","vu","mussolin","reyes","others"],"title":"Polyclonal secondary FGFR2 mutations drive acquired resistance to FGFR inhibition in FGFR2 fusion-positive cholangiocarcinoma patients","year":2017}